Biomarkers: Validation and Verification

The biomarker validation study represents a key step for the translation of the bench findings into clinical practice for tailored prescription or to accelerate the development of new drugs and other medical products. Biomarker validation is a multifaceted procedure that requires collaboration of multiple clinical centers and carries a significant financial burden and for which robust quantitative assays have been developed will enter the validation phase.

  • Biomarker validation
  • Biomarker identification

Related Conference of Biomarkers: Validation and Verification

July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE

Biomarkers: Validation and Verification Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in